Skip to main content
. 2022 Jun 6;28(5):702–712. doi: 10.1111/hae.14595

FIGURE 4.

FIGURE 4

Summary of total TFPI levels over the duration of the study for participants who did and did not experience serious adverse events. LLOQ, lower limit of quantification; SAE, serious adverse event; TFPI, tissue factor pathway inhibitor